GETI.B

193.55

-0.08%↓

VITR

161.1

+2.16%↑

AMBEA

109

+1.77%↑

ARJOB

31.02

-0.51%↓

MSON.B

8.7

-0.46%↓

GETI.B

193.55

-0.08%↓

VITR

161.1

+2.16%↑

AMBEA

109

+1.77%↑

ARJOB

31.02

-0.51%↓

MSON.B

8.7

-0.46%↓

GETI.B

193.55

-0.08%↓

VITR

161.1

+2.16%↑

AMBEA

109

+1.77%↑

ARJOB

31.02

-0.51%↓

MSON.B

8.7

-0.46%↓

GETI.B

193.55

-0.08%↓

VITR

161.1

+2.16%↑

AMBEA

109

+1.77%↑

ARJOB

31.02

-0.51%↓

MSON.B

8.7

-0.46%↓

GETI.B

193.55

-0.08%↓

VITR

161.1

+2.16%↑

AMBEA

109

+1.77%↑

ARJOB

31.02

-0.51%↓

MSON.B

8.7

-0.46%↓

Search

Vivesto AB

Aperta

0.22

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

0.22

Massimo

0.22

Metriche Chiave

By Trading Economics

Entrata

-451K

-11M

EPS

-0.02

Dipendenti

4

Dividendi

By Dow Jones

Utili prossimi

12 ago 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-5.9M

124M

Apertura precedente

0.22

Chiusura precedente

0.22

Vivesto AB Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

18 mag 2025, 23:47 UTC

Discorsi di Mercato

Nikkei May Trade Rangebound Amid Uncertainty Over U.S. Tariffs -- Market Talk

18 mag 2025, 23:40 UTC

Discorsi di Mercato

Gold Rises Amid Concerns Over U.S. Fiscal Deficit -- Market Talk

18 mag 2025, 18:00 UTC

Utili

Tax Bill News; Target, Home Depot, and Snowflake Earnings; and More Stock Market News to Watch This Week -- Barrons.com

18 mag 2025, 17:01 UTC

Notizie principali

GM Is Fighting California on EVs. This Is What It Wants to Overturn and Why. -- Barrons.com

18 mag 2025, 16:20 UTC

Utili

Tesla Demand Hasn't Rebounded Yet. Watch China This Week. -- Barrons.com

18 mag 2025, 12:09 UTC

Notizie principali

Trump Sounds Upbeat on Ukraine Cease-Fire as Russia Unleashes Drone Barrage -- WSJ

17 mag 2025, 17:15 UTC

Notizie principali

Trump Attacks Walmart for Tariff-Related Price Increases -- WSJ

17 mag 2025, 09:30 UTC

Notizie principali
Utili

In a Trade War, Walmart Lacks Some of Amazon's Ammunition -- Heard on the Street -- WSJ

17 mag 2025, 08:20 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

17 mag 2025, 08:20 UTC

Discorsi di Mercato
Utili

Financial Services Roundup: Market Talk

16 mag 2025, 23:18 UTC

Notizie principali

U.S. Loses Last Triple-A Credit Rating -- 2nd Update

16 mag 2025, 22:30 UTC

Notizie principali

U.S. Loses Last Triple-A Credit Rating -- Update

16 mag 2025, 21:56 UTC

Discorsi di Mercato

Fitch Raises Greece's Outlook to Positive From Stable -- Market Talk

16 mag 2025, 21:56 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

16 mag 2025, 21:54 UTC

Notizie principali

U.S. Loses Last Triple-A Credit Rating -- WSJ

16 mag 2025, 21:22 UTC

Discorsi di Mercato

Moody's Says U.S. Fiscal Performance Likely to Deteriorate -- Market Talk

16 mag 2025, 21:17 UTC

Discorsi di Mercato

Treasury Yields Rise, Dollar Falls After Moody's Cuts U.S. Credit Rating -- Market Talk

16 mag 2025, 21:17 UTC

Notizie principali

The Score: UnitedHealth, Walmart, Coinbase Global and More Stocks That Moved on the Week's News -- WSJ

16 mag 2025, 21:05 UTC

Discorsi di Mercato

Moody's Downgrades U.S. Credit Rating Due to Deficit, Debts -- Market Talk

16 mag 2025, 20:55 UTC

Acquisizioni, Fusioni, Takeovers

What's Next for Cable Giant Comcast After Charter-Cox Merger -- Barrons.com

16 mag 2025, 20:50 UTC

Discorsi di Mercato
Utili

Financial Services Roundup: Market Talk

16 mag 2025, 20:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

16 mag 2025, 20:37 UTC

Notizie principali

Trade Progress Sparks Bullish Week for Wall Street -- WSJ

16 mag 2025, 20:33 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Dick's-Foot Locker Deal Looks Like a Bet on Nike's Turnaround -- Market Talk

16 mag 2025, 20:30 UTC

Acquisizioni, Fusioni, Takeovers

Galaxy Digital Begins U.S. Trading as Bitcoin Keeps Powering Ahead -- Barrons.com

16 mag 2025, 20:18 UTC

Notizie principali

Major U.S. Stock Indexes Rise; U.S. Running Out of Patience for Trade Deals -- WSJ

16 mag 2025, 20:16 UTC

Notizie principali

Justice Department Wants to Spare Boeing From Guilty Plea Over 737 MAX Charges -- 3rd Update

16 mag 2025, 20:15 UTC

Utili

Tesla Stock Rises. Even Hedge Fund Sales Can't Keep It Down. -- Barrons.com

16 mag 2025, 20:11 UTC

Acquisizioni, Fusioni, Takeovers

Henry Schein: William K. Daniel Joins Board

16 mag 2025, 20:10 UTC

Acquisizioni, Fusioni, Takeovers

Henry Schein: Strategic Investment by KKR Completed

Confronto tra pari

Modifica del prezzo

Vivesto AB Previsione

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Vivesto AB

Vivesto AB develops, produces, markets, and sells drugs in the field of human and veterinary oncology in Sweden. Its lead product is Apealea (paclitaxel micellar) for the treatment of ovarian cancer. The company's products portfolio includes Docetaxel micellar, a patented formulation that combines cytotoxin docetaxel with XR-17, which is in Phase 1b clinical trial for the treatment of prostate cancer; and Cantrixil to treat ovarian cancer. its animal health product portfolio includes Paccal Vet, a formulation of paclitaxel with its XR-17 encapsulation technology for the treatment of canine mastocytoma; and Doxophos Vet, a patented formulation of doxorubicin to treat lymphoma. The company was formerly known as Oasmia Pharmaceutical AB (publ) and changed its name to Vivesto AB in March 2022. Vivesto AB was incorporated in 1988 and is headquartered in Solna, Sweden.